Predicting the in vivo mechanism of action for drug leads using NMR metabolomics
about
Analysis of bacterial biofilms using NMR-based metabolomicsSimultaneous Analysis of Major Coenzymes of Cellular Redox Reactions and Energy Using ex Vivo (1)H NMR SpectroscopyEmerging Approaches to Tuberculosis Drug Development: At Home in the Metabolome.Rapid clinical bacteriology and its future impactMultivariate statistical models of metabolomic data reveals different metabolite distribution patterns in isonitrosoacetophenone-elicited Nicotiana tabacum and Sorghum bicolor cellsThe current state of drug discovery and a potential role for NMR metabolomics.Mycobacterium tuberculosis metabolismRevisiting Protocols for the NMR Analysis of Bacterial MetabolomesNMR Metabolomics Analysis of Parkinson's DiseaseCharacterization and prediction of the mechanism of action of antibiotics through NMR metabolomics.Utilities for quantifying separation in PCA/PLS-DA scores plots.Analysis of serum metabolic profile by ultra-performance liquid chromatography-mass spectrometry for biomarkers discovery: application in a pilot study to discriminate patients with tuberculosis.The future of NMR metabolomics in cancer therapy: towards personalizing treatment and developing targeted drugs?Simultaneous Phase and Scatter Correction for NMR Datasets.Natural Products Diversity of Marine Ascidians (Tunicates; Ascidiacea) and Successful Drugs in Clinical Development.Use of Charged Nanoparticles in NMR-Based Metabolomics for Spectral Simplification and Improved Metabolite Identification.In vitro and in vivo studies of a rapid and selective breath test for tuberculosis based upon mycobacterial CO dehydrogenase.Determination of antiprotozoal drug mechanisms by metabolomics approaches.Integrative metabolomics as emerging tool to study autophagy regulation.Metabolite profiling of ascidian Styela plicata using LC-MS with multivariate statistical analysis and their antitumor activity.Comparative mass spectrometry-based metabolomics strategies for the investigation of microbial secondary metabolites.The role of metabolomics in tuberculosis treatment research.In vitro susceptibility and cellular uptake for a new class of antimicrobial agents: dinuclear ruthenium(II) complexes.Macrophage-Mediated Clofazimine Sequestration Is Accompanied by a Shift in Host Energy Metabolism.Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824).A framework for large-scale metabolome drug profiling links coenzyme A metabolism to the toxicity of anti-cancer drug dichloroacetate
P2860
Q26851303-B870E75F-C82F-47F6-B96E-1B9E009D0CA4Q28833532-4FBAD5B3-0DF1-4C88-B05F-0E469D921A98Q30236042-B2E2E010-BB3B-4866-A65D-FDAEDB6888D0Q30459288-A1E6E35B-7D82-46FB-A6BD-C77BA21F8F27Q30831626-129E2E29-AAAC-4FE6-8A27-2DE34382C737Q35072850-AF847B60-4110-43EE-B198-C2816C7786FFQ35245286-8E13710A-FD9B-4490-BEC5-14E491376AE4Q35733896-1537D6CD-C492-4CFD-ABE0-38337397B2A1Q35734379-87D69B9A-6CEA-437A-A914-F7FC070EEDFAQ36012460-0F8E514C-D4BF-4337-9FC1-D961995396D4Q36501475-17F219C9-B45A-4882-94E7-28CDEE8817DDQ36816275-51761C52-830E-4FC3-922F-3EE95035C6CAQ37512764-5E01F624-C2CA-410B-9878-E3816955DF85Q37533015-7D8C2054-BD0E-4BEF-A111-A737D94245D6Q37650544-E951719C-7DB1-4ACA-A680-86A52F3987B4Q37712006-B76865A2-C56E-4C9E-A4FF-8FA2A7BBA9EFQ37714067-C0FC79C7-FE3E-4504-9A31-13D271A3CDB2Q38111816-F4A183E5-C4C4-4094-9821-21CB0B2F878BQ38636818-7FA02A5A-DCF0-4860-B4F6-55FACFBA2BE2Q38715058-53955FBC-86D0-4C62-BAA3-B0D3B8310813Q38823592-47FF21E2-4629-412E-84AE-D4EB48CCE8E3Q46462804-00E8FCD4-A20B-4874-8433-997F5DBBE6A1Q51336829-3C083DA3-6A0A-4B70-859E-6F06EA0532E9Q52677571-221E9BAE-B2A5-432F-8AF8-76FD66EEF541Q55116823-6748452A-4683-4BBD-ACCD-3994FF2CE766Q57135523-FC47D17A-F56D-400A-A8B3-4FEDABD35392
P2860
Predicting the in vivo mechanism of action for drug leads using NMR metabolomics
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Predicting the in vivo mechanism of action for drug leads using NMR metabolomics
@ast
Predicting the in vivo mechanism of action for drug leads using NMR metabolomics
@en
type
label
Predicting the in vivo mechanism of action for drug leads using NMR metabolomics
@ast
Predicting the in vivo mechanism of action for drug leads using NMR metabolomics
@en
prefLabel
Predicting the in vivo mechanism of action for drug leads using NMR metabolomics
@ast
Predicting the in vivo mechanism of action for drug leads using NMR metabolomics
@en
P2093
P2860
P356
P1433
P1476
Predicting the in vivo mechanism of action for drug leads using NMR metabolomics
@en
P2093
Raúl G Barletta
Robert J Fenton
Robert Powers
Steven Halouska
P2860
P304
P356
10.1021/CB200348M
P577
2011-12-01T00:00:00Z